A New Blockchain And AI Platform Will Diagnose Rare Diseases

A growing number of children are diagnosed with congenital diseases that are rare and hence pose a challenge to health practitioners charged with their diagnosis. Additionally, these conditions have a far-reaching and devastating burden of disease to parents, relatives, and the community at large.

As the world marks the Rare Disease Day, the Global Commission to End the Diagnostic Odyssey for Children with a Rare Diseases has launched a pilot project that is using Blockchain and Artificial Intelligence to diagnose these conditions.

Microsoft Backs The Platform

Microsoft will take part in offering technical assistance in the development and management of the platform. The input of the tech giant will ensure that Blockchain technology, machine learning, and Artificial Intelligence are integrated into the hybrid platform that parents, doctors, and other concerned parties can use to link symptoms with possible conditions.

artificial intelligence

The pilot has been launched on February 28th and all stakeholders are positive that it will address all the shortcomings of the conventional diagnostic methods.

Additionally, the platform will be conveying practical solutions that communities affected by rare diseases can adapt to manage the conditions.

About Rare Diseases

Reports from the Global Genes show that there are an estimated 7,000 proven types of rare diseases affecting a whopping 350 million people directly and hundreds of millions indirectly.

The impacts of these conditions are devastating and this is the main reason that the 12th international Rare Disease Day is being marked to highlight the plight of the affected.

The European Organization for Rare Diseases (EURORDIS) has been liaising with Takeda pharmaceutical company from Japan as well as Microsoft to create the state-of-the-art platform.

Using Blockchain To Improve The Quality Of Life

According to the head of medical affairs in charge of internal medicine and rare diseases at Takeda, Dr. Hartmann Wellhoefer, “an accurate and timely diagnosis” is the fundamental factor that holds the key to a better, longer, and healthier life for any child living with a rare disease.

Dr. Hartmann reveals that it takes an average of 5 years for a conclusive and accurate diagnosis to be made. Further, 40% of the rare disease patients are wrongly diagnosed which hampers any meaningful medical intervention.

However, this is set to change and the pilot project is the beginning of the establishment of the life-changing platform.

The first pilot is starting in Beijing with the support of the Chinese Organization for Rare Disorders (CORD). The second will be at Washington DC’s Children’s National Hospital, and the final will be undertaken in Switzerland.

Technical Aspects Of The Platform

The new platform will offer remote counseling, a combination of genetic assessments, as well as “intelligent triage” that ranks the urgency of illnesses or wounds treatment. All these solutions will be supported by telemedicine and virtual tools.

Remote counseling will be supported by facial recognition using AI. Blockchain technology will be applied in managing data for patients which is the cornerstone of the platform. DLT will also ensure that data is private and only accessible with permission from patients.